A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 in Japanese Healthy Participants

Summary

The purpose of the study is to assess the safety, pharmacokinetics (what the body does to the drug) and immunogenicity (ability of a particular substance to provoke an immune response in the human body) of CR6261 in Japanese healthy participants

Timeline

Start

2013-12

Primary completion

2014-01

Completion

2014-04

Outcome

Outcome not reported

Stopped (Business): “Study terminated due to business decision”

Drugs

Indications

No indication recorded.